ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0404

Correlation of Urinary Electrolyte Excretion Fractions with AKI Severity in Patients in the Intensive Care Unit

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • De La Torre, Juana Citlali, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, CDMX, Mexico
  • Alamilla-Sanchez, Mario, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, CDMX, Mexico
  • Ulloa Galvan, Victor Manuel, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, CDMX, Mexico
  • Ruiz Rivera, Fani Guadalupe, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, CDMX, Mexico
  • Salazar Hurtado, Jorge David, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, CDMX, Mexico
  • Gonzalez-Fuentes, Carolina, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, CDMX, Mexico
Background

Acute Kidney Injury (AKI) ipresents in up to 70% of patients in the Intensive Care Unit (ICU). The most commonly used biomarker is serum creatinine, which has proven to be inadequate. Proximal tubular secretion function is infrequently measured during an AKI episode.

Methods

A cross-sectional study was conducted. The objetive of the study was to identify if urine electrolyte excretation correlates with the severity of acute kidney injury.

Results

Analysis of urinary indices documented a median fractional excretion of sodium (FeNa) reported at 1.49 (0.40–4.39). The mean fractional excretion of phosphorus (FeP) was 30.52 ± 24. The mean FeMg was 14.48 ± 21.8. The fractional excretion of calcium (FeCa) showed a median of 1.21 (0.41–3.67). The urinary potassium-to-urinary creatinine ratio (Ku/CrU) was evaluated, with a median of 13.03 (9.21–15.00) mEq/g. creatinine-to-serum creatinine ratio (UCr/SCr), a median of 25.9 (12.48–48.5) mg/dL The protein-to-creatinine index (PCI) showed a median of 0.45 (0.17–1.25) mg/mg. Urinary beta-2 microglobulin showed a median of 0.14 (0.02–0.37) mg/L, Correlation with renal recovery, FeNa >3: OR 1.42 (0.56–3.6) FeP >15: OR 1.36 (0.46–4.02), FeCa >2: OR 1.02 (0.35–2.66), FeMg >4: OR 0.97 (0.32–2.7), PCI >0.5: OR 0.12 (0.031–0.148), urinary osmolarity was 334.5 it corraletes with kidney recovery with a AUC curve with 0.71 with a sensibility 0.86 and specificity of 0.7.

Conclusion

In patients with AKI, tubular function tends to manifest through urinary losses of sodium, phosphorus, and magnesium, as well as a failure to reabsorb urinary beta-2 microglobulin. However, the alteration of these urinary indices does not increase the risk of severity for this condition, as part of the analysis we found that urinary osmolarity corralates with concentration capacity during an AKI can be a predictive marker of kidney function recovery.

AUC Osmolarity and kidney recovery